Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)

The purpose of this FOA is to solicit applications for the Data Management and Coordination Unit (DMCU), one of the two components of the Precompetitive Collaboration on Liquid Biopsy for Early-Cancer Assessment Consortium (LBC). LBC is an Academic-Industrial Partnership program to develop and validate liquid biopsy technologies for early-cancer detection, risk assessment, and/or for distinguishing cancer from benign disease or aggressive from indolent cancers. The DMCU will be responsible for: (1) Consortium Coordination; (2) Statistical and Computational Analysis Support; and (3) Data Management and Protocol Development.

The other component of LBC is the Liquid Biopsy Research Laboratories (LBRLs). The LBRLs will conduct research on the development of liquid biopsy technologies, assays and/or methods for the capture and analysis of tumor associated cells, DNA, RNA, or exosomes in body fluids of individuals with early-stage cancer or at high risk of developing the disease.